Swiss National Bank Arvinas, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Arvinas, Inc. stock. As of the latest transaction made, Swiss National Bank holds 94,000 shares of ARVN stock, worth $2.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

94,000

Previous 94,000 -0.0%

Holding current value

$2.36 Million

Previous $2.5 Million 7.47%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$24.46 - $40.4 $491,646 - $812,040	-20,100 Reduced 17.62%	94,000 $2.5 Million
Q1 2024 May 07, 2024	BUY	$36.38 - $52.31 $894,948 - $1.29 Million	24,600 Added 27.49%	114,100 $4.71 Million
Q4 2023 Feb 06, 2024	SELL	$14.19 - $42.33 $144,738 - $431,766	-10,200 Reduced 10.23%	89,500 $3.68 Million
Q3 2023 Nov 08, 2023	BUY	$19.64 - $28.21 $23,568 - $33,852	1,200 Added 1.22%	99,700 $1.96 Million
Q2 2023 Aug 09, 2023	BUY	$21.73 - $31.43 $19,557 - $28,287	900 Added 0.92%	98,500 $2.44 Million
Q1 2023 May 10, 2023	SELL	$26.15 - $37.26 $303,340 - $432,216	-11,600 Reduced 10.62%	97,600 $2.67 Million
Q4 2022 Feb 08, 2023	BUY	$32.47 - $57.24 $64,940 - $114,480	2,000 Added 1.87%	109,200 $3.74 Million
Q3 2022 Nov 09, 2022	BUY	$41.87 - $57.99 $54,431 - $75,387	1,300 Added 1.23%	107,200 $4.77 Million
Q2 2022 Aug 09, 2022	BUY	$36.01 - $74.24 $439,322 - $905,727	12,200 Added 13.02%	105,900 $4.46 Million
Q1 2022 May 09, 2022	BUY	$60.27 - $81.57 $753,375 - $1.02 Million	12,500 Added 15.39%	93,700 $6.31 Million
Q3 2021 Nov 08, 2021	BUY	$73.2 - $107.87 $190,320 - $280,462	2,600 Added 3.31%	81,200 $6.67 Million
Q2 2021 Aug 06, 2021	BUY	$60.45 - $84.26 $477,555 - $665,654	7,900 Added 11.17%	78,600 $6.05 Million
Q1 2021 May 07, 2021	BUY	$58.19 - $91.37 $46,552 - $73,096	800 Added 1.14%	70,700 $4.67 Million
Q4 2020 Feb 05, 2021	BUY	$20.19 - $84.93 $514,845 - $2.17 Million	25,500 Added 57.43%	69,900 $5.94 Million
Q3 2020 Nov 09, 2020	BUY	$22.99 - $36.34 $20,691 - $32,706	900 Added 2.07%	44,400 $1.05 Million
Q2 2020 Aug 05, 2020	BUY	$29.88 - $56.74 $170,316 - $323,418	5,700 Added 15.08%	43,500 $1.46 Million
Q1 2020 May 08, 2020	BUY	$33.0 - $54.5 $39,600 - $65,400	1,200 Added 3.28%	37,800 $1.52 Million
Q4 2019 Feb 06, 2020	BUY	$15.39 - $44.38 $240,084 - $692,328	15,600 Added 74.29%	36,600 $1.5 Million
Q2 2019 Aug 02, 2019	BUY	$15.96 - $23.8 $335,160 - $499,800	21,000 New	21,000 $462,000

Others Institutions Holding ARVN

# of Institutions

229

Shares Held

68.4M

Call Options Held

226K

Put Options Held

285K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.34B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Arvinas, Inc. Transaction History